Clinical trial
Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults
NCT00249106 · International AIDS Vaccine Initiative, Other · Completed
Key facts
| NCT number | NCT00249106 |
|---|---|
| Title | Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults |
| Official title | Randomized, Placebo-Controlled, Dose-Escalating, Double-Blinded Phase 1 Safety and Immunogenicity Study of Clade C DNA Vaccine ADVAX e/g + ADVAX p/N-t (ADVAX) Administered Intramuscularly to HIV-Uninfected, Healthy Volunteers. |
| Acronym | C001 |
| Lead sponsor | International AIDS Vaccine Initiative, Other |
| Collaborators | Aaron Diamond AIDS Research Center University of Rochester |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Biological |
| Interventions | ADVAX |
| Enrollment | 45 |
| Start date | Dec 1, 2003 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Nov 7, 2005 |
| Last update posted | Feb 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: